Tbilisi

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Graves' disease and hyperthyroidism2 trials
• Myasthenia gravis2 trials
• Rheumatoid arthritis1 trial

Phase

• Phase 23 trials
• Phase 32 trials

Status

• Recruiting3 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Immunovant Sciences GmbH5 trials

Running trials

• Recruiting

  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  NCT07018323· Phase 2· Immunovant Sciences GmbH· Source

• Recruiting

  Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

  NCT07039916· Phase 3· Immunovant Sciences GmbH· Source

• Active, not recruiting

  A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis

  NCT06754462· Phase 2· Immunovant Sciences GmbH· Source

• Recruiting

  A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

  NCT06727604· Phase 2· Immunovant Sciences GmbH· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Graves' disease and hyperthyroidism2 recruiting
• Myasthenia gravis1 recruiting

Closed trials

• Terminated

  Phase 3 Study to Assess the Efficacy and Safety of Batoclimab as Induction and Maintenance Therapy in Adult Participants With Generalized Myasthenia Gravis

  NCT05403541· Phase 3· Immunovant Sciences GmbH· Source